| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/20/2007 | CN1322134C Expression system |
| 06/20/2007 | CN1322133C Wheat anti-powdery mildew gene Pm21 linked codorminant PCR marker and its usage |
| 06/20/2007 | CN1322132C Engineering bacteria for producing 5-amino acetyl propionic acid and its constructing method |
| 06/20/2007 | CN1322131C Plasmid on operating platform for knocking out gene of plant in cereal, construction method and application |
| 06/20/2007 | CN1322130C Genes encoding proteins having transglycosylation activity |
| 06/20/2007 | CN1322129C Novel carbonyl reductase, gene encoding it and process for producing optically active alcohols using the same |
| 06/20/2007 | CN1322128C MIP gene clone, recombination, expression and protein purifying method for Legionlla pneumophila |
| 06/20/2007 | CN1322127C BASB029 polynucleotide(s) and polypeptides from i(neisseria meningitidis) |
| 06/20/2007 | CN1322126C Identification, production and use of staphylokinase derivatives with reduced immunogenicity and/or reduced clearance |
| 06/20/2007 | CN1322125C Paddy rice zinc finger protein gene and its coded protein |
| 06/20/2007 | CN1322124C Gene of coding cobweb protein and use thereof |
| 06/20/2007 | CN1322123C Recombinant serine protease and fungicide containing the same |
| 06/20/2007 | CN1322122C Xylanase, production and special producing strain thereof |
| 06/20/2007 | CN1322121C Hyaluronan synthase gene and uses thereof |
| 06/20/2007 | CN1322120C Bivalent hepatitis B-encephalitis B vaccine |
| 06/20/2007 | CN1322110C Yeast gene engineering bacteria and heat resistant alkali resistant xylanase preparation and application method |
| 06/20/2007 | CN1322009C Monoclonal antibody of virus receptor of anti leukoplakia disease and preparation method |
| 06/20/2007 | CN1322007C Antibacterial peptide DC and its preparing process and use |
| 06/20/2007 | CN1322003C Methods of producing target molecule in transgenic animal and purification of target molecule |
| 06/20/2007 | CN1321695C Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases |
| 06/20/2007 | CN1321693C Over-expressing homologous antigen vaccine and method of making same |
| 06/20/2007 | CN1321689C Use of disintegrain domain of adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent |
| 06/20/2007 | CN1321688C Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation |
| 06/19/2007 | USRE39696 Human cyclooxygenase-2 cDNA and assays for evaluating cyclooxygenase-2 activity |
| 06/19/2007 | US7232945 Plants and seeds of corn variety I226211 |
| 06/19/2007 | US7232942 Lentil plants having increased resistance to imidazolinone herbicides |
| 06/19/2007 | US7232941 Cellulose synthase promoter and method for modifying cellulose and lignin biosynthesis in plants |
| 06/19/2007 | US7232940 Moderation of gene expression in plants; transformed cell |
| 06/19/2007 | US7232939 nucleic acids encoding cyclotides characterized by activity against plant pathogens including Sclerotinia scierotiorum, Panagrellus redivivus and C. elegans; plants, especially soybeans, having stably incorporated into its genome a DNA construct containing the nucleotide sequence |
| 06/19/2007 | US7232938 Cloning ungulates from a quiescent donor cell |
| 06/19/2007 | US7232899 Targeted plasmids comprising viral tripartite leader (TPL) sequences for facilitating development of high capacity gene therapy/transfer tools |
| 06/19/2007 | US7232898 Chimeric IgE polypeptides and host cells |
| 06/19/2007 | US7232890 Diagnosis, therapy of breast cancer; adjustment of gene expression |
| 06/19/2007 | US7232887 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 06/19/2007 | US7232885 for genetically engineered proteins with increase in solubility and in vivo stability and a decrease in immunogenicity |
| 06/19/2007 | US7232880 Mutant IGFBP-3 molecules that do not bind to IGFS, but retain their ability to functionally bind IGFBP-3 receptor |
| 06/19/2007 | US7232807 An RNA molecule having a sequence portion that has affinity to at least one consensus sequence present in an agglomeration nucleic acid-binding protein; detection of affinity complex formed confirms diagnoses of diseases such as spongiform encephalopathies |
| 06/19/2007 | US7232806 Small temporal RNA rannging from 21 and 22 base pairs for use regulatory modulators of gene expression; treatment and prevention of cell proliferative disorders |
| 06/19/2007 | US7232800 for a cleavage reagent while preserving the anti-microbial activity; reagent includes alkaline protease such as trypsin and clotrispain; genetic engineering |
| 06/19/2007 | US7232685 Cell lines with latent immunodeficiency virus and methods of use thereof |
| 06/19/2007 | US7232684 DNA encoding hyaluronan synthase from Pasteurella multocida and methods of use |
| 06/19/2007 | US7232682 Expression vectors encoding epitopes of target-associated antigens and methods for their design |
| 06/19/2007 | US7232680 For producing vaccine for protecting a mammal or a bird from infection by a Nidovirales virus |
| 06/19/2007 | US7232679 Comprises sequences coding hydroxymethylglutaryl-CoA reductase (HMG-COA reductase), isopentenyl diphosphate isomerase (IDI), mevalonate kinase, hydroxymethylglutaryl-CoA synthase (HMG-CoA synthase) for biosynthesis of zeaxanthin |
| 06/19/2007 | US7232678 Identification of oligoadenylate synthetase-like genes |
| 06/19/2007 | US7232677 Nucleotide sequences for use in treatment of digestion defects in plants and animals |
| 06/19/2007 | US7232676 Chondroitin synthase and nucleic acid encoding the enzyme |
| 06/19/2007 | US7232675 Sulfotransferase, its polypeptide and DNA encoding the same |
| 06/19/2007 | US7232674 Process for producing α1,4-galactosyltransferase and galactose-containing complex sugar |
| 06/19/2007 | US7232673 Antimicrobial protein from Lyophyllum shimeji |
| 06/19/2007 | US7232672 P450 enzymes, nucleic acids encoding them and methods of making and using them |
| 06/19/2007 | US7232668 Fc fusion proteins of human granulocyte colony-stimulating factor with increased biological activities |
| 06/19/2007 | US7232667 Keratinocyte growth factor-2 polynucleotides |
| 06/19/2007 | US7232666 For the production of carotenoid compounds through the down-regulation of various genes in the carotenoid biosynthetic pathway |
| 06/19/2007 | US7232665 Carotenoid overproducing microorganism comprising genes coding functional isoprenoid enzymatic biosynthetic pathway for use in pharmaceuticals, food supplements, electro-optics, animal feed additives and colorants in cosmetics |
| 06/19/2007 | US7232664 Preparing and recovering lactic acid for use in cosmetics, foods, drugs and plastics from genetically engineered yeast comprising defect in pyruvate decarboxylase pathway |
| 06/19/2007 | US7232662 Comprises nucleotide sequences coding stearoyl-coa desaturases for diagnosis, prevention and treatment of atherosclerosis and cardiovascular disease |
| 06/19/2007 | US7232660 Bioassay for detection of membrane protein receptor ligand associated with modulation of hodgkin's disease; carrier for delivering diagnostic and cytotoxic agents to tumors; gene therapy |
| 06/19/2007 | US7232658 A method of identifying agents that modulate the activity of a lepidopteran glutamate-gated chloride channel ; agents are useful as insecticides |
| 06/19/2007 | US7232655 Method and probe set for detecting cancer |
| 06/19/2007 | US7232653 Cancer cells from body fluids containing cells, isolation thereof and agents containing the same |
| 06/19/2007 | US7232569 Type III secretion pathway in aeromonas salmonicida, and uses therefor |
| 06/19/2007 | US7232563 A fusion proteins having the C-terminal region of the interfero protein is replaced by a C-terminal region of tau proteins; viricides, antiproliferation agents, antiinflammatory agents; lower cytotoxic side effects |
| 06/19/2007 | US7232562 E38N interferon gamma polypeptide variants |
| 06/19/2007 | CA2372990C Means for detecting and treating pathologies linked to fgfr3 |
| 06/19/2007 | CA2287478C Methods for increasing the efficiency of recombinant aav product |
| 06/19/2007 | CA2281830C Methods of commercial production and extraction of protein from seed |
| 06/19/2007 | CA2257304C Perlecan transgenic animals and methods of identifying compounds for the treatment of amyloidoses |
| 06/19/2007 | CA2159112C Anti-microbial agents and screening method therefor |
| 06/19/2007 | CA2158745C Inhibitor of vascular endothelial cell growth factor |
| 06/19/2007 | CA2098171C Genetically engineered modification of potato to form amylopectin-type starch |
| 06/19/2007 | CA2073124C Tumor antigen specific antibody |
| 06/19/2007 | CA2013582C Method for enhancing transmembrane transport of exogenous molecules |
| 06/19/2007 | CA1341532C Heterologous polypeptides expressed in filamentous fungi, processes for making same, and vectors for making same |
| 06/15/2007 | CA2632289A1 Protein-protein interaction detection system using fluorescent protein microdomains |
| 06/15/2007 | CA2569062A1 Recombinant triplex scaffold-based polypeptides |
| 06/14/2007 | WO2007067981A2 RNA INTERFERENCE MEDIATED INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 06/14/2007 | WO2007067907A1 Reverse transcription primers and methods of design |
| 06/14/2007 | WO2007067896A1 Method for determining vasoreactivity |
| 06/14/2007 | WO2007067818A2 Plasmids and packaging cell lines for use in phage display |
| 06/14/2007 | WO2007067782A2 Compositions and methods for inducing the activation of immature monocytic dendritic cells |
| 06/14/2007 | WO2007067564A2 Improved host cells and culture methods |
| 06/14/2007 | WO2007067183A1 Derivation of unlimited quantities of neutrophils or monocyte/dendritic cells |
| 06/14/2007 | WO2007066823A1 Antibody against connective tissue growth factor or composition containing the same |
| 06/14/2007 | WO2007066809A1 Protein which can serve as nucleus for polymerization of protein polymer, cell having the polymer introduced therein, and process for production of the cell |
| 06/14/2007 | WO2007066799A1 Method for evaluation of compound capable of acting on plk1 |
| 06/14/2007 | WO2007066794A1 Brak-knockout nonhuman animal |
| 06/14/2007 | WO2007066779A1 Novel lipase |
| 06/14/2007 | WO2007066775A1 TRANSGENIC FOWL HAVING Gla RESIDUE IN PROTEIN DERIVED FROM FOREIGN GENE |
| 06/14/2007 | WO2007066737A1 Method for replication of nucleic acid and novel artificial base pair |
| 06/14/2007 | WO2007066708A1 INDUCTION OF HARD TISSUE FORMATION RELYING ON Wnt5a/SFRP4 SIGNAL SYSTEM |
| 06/14/2007 | WO2007066698A1 Genetically recombinant anti-perp antibody |
| 06/14/2007 | WO2007066665A1 METHOD FOR PREPARATION OF cRNA |
| 06/14/2007 | WO2007066627A1 Multi-purpose acylation catalayst and use thereof |
| 06/14/2007 | WO2007066595A1 Process for production of ceramide using transformed yeast |
| 06/14/2007 | WO2007066430A1 Process for producing peptide |
| 06/14/2007 | WO2007066423A1 Tumor antigen peptide derived from amacr |
| 06/14/2007 | WO2007066214A2 Nucleic acids and methods for producing seeds having a full diploid complement of the maternal genome in the embryo |
| 06/14/2007 | WO2007065957A2 Methods for generating antigen-specific effector t cells |
| 06/14/2007 | WO2007065950A1 Method for enriching short-chain nucleic acids |